Chemoprevention of Gastric Cancer: Metformin
نویسندگان
چکیده
منابع مشابه
GASTRIC CANCER Chemoprevention of gastric cancer by celecoxib in rats
Background: Overexpression of cyclooxygenase 2 (COX-2) is frequently detected in gastric cancer and is believed to play a crucial role in gastric carcinogenesis. Aim: We examined the chemopreventive effect of a COX-2 inhibitor in an animal model of stomach carcinogenesis. Methods: Eighty six male Wistar rats were divided into six different treatment groups: group A, water alone (n = 5); group B...
متن کاملAssociation of Diabetes and Metformin Use with Gastric Cancer: A Case-Control Study
Background and purpose: Recently, several studies have shown type 2 diabetes to be associated with gastric cancer and metformin appears to inhibit the growth of cancer cells by inducing apoptosis. This study was conducted to investigate the relationship between metformin and gastric cancer. Materials and methods: This case-control study included patients with gastric cancer (case group, n= 12...
متن کاملChemoprevention of gastric cancer by celecoxib in rats.
BACKGROUND Overexpression of cyclooxygenase 2 (COX-2) is frequently detected in gastric cancer and is believed to play a crucial role in gastric carcinogenesis. AIM We examined the chemopreventive effect of a COX-2 inhibitor in an animal model of stomach carcinogenesis. METHODS Eighty six male Wistar rats were divided into six different treatment groups: group A, water alone (n = 5); group ...
متن کاملNovel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancer.
Recent evidence shows that commonly prescribed drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs), metformin, and statins, may have beneficial roles in the primary chemoprevention of breast cancer. Therefore, these drugs could potentially be used in addition to the hormonal drugs currently used for this purpose (namely, selective estrogen receptor modulators and aromatase inhibitors)...
متن کاملDoes long-term metformin usage reduce gastric cancer risk?
The study reported by Kim YI et al. (1) will be published April 2014 issue in Alimentary Pharmacology & Therapeutics. The authors randomly selected 100,000 type 2 diabetic patients from the 2004 Korean National Health Insurance claim database, and assessed gastric cancer incidence among 39 989 patients who were regularly treated with anti-diabetic drugs and followed-up from 2004 to 2010. In tot...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Korean Journal of Helicobacter and Upper Gastrointestinal Research
سال: 2017
ISSN: 1738-3331
DOI: 10.7704/kjhugr.2017.17.4.179